vers la météo de la validation par utilisateur

Ingenuity308

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 86 - PMID ?

In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                               +-------------COMP:N-N(of)------------+                      |                                              
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            +--------COMP:N-N(of)-------+     
       |                                   |                               |            |                        +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |                   |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 1 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                               +-------------COMP:N-N(of)------------+                      |                                              
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            +--------COMP:N-N(of)-------+     
       |                                   |                               |            |                        +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |                   |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 2 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +--------COMP:N-N(of)-------+     
       |                                   |                                                                     +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |                   |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 3 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            +--------COMP:N-N(of)-------+     
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            |           +-MOD_ATT:N-ADJ-+     
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |                   |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 4 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +--------COMP:N-N(of)-------+     
       |                                   |                                                                     +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |                   |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 5 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            +--------COMP:N-N(of)-------+     
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            |           +-MOD_ATT:N-ADJ-+     
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |                   |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 6 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +--------COMP:N-N(of)-------+     
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |                   |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 7 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +--------COMP:N-N(of)-------+     
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |                   |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 8 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                               +-------------COMP:N-N(of)------------+                      |                                              
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            +--------COMP:N-N(of)-------+     
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |      |            |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 9 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                               +-------------COMP:N-N(of)------------+                      |                                              
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            +--------COMP:N-N(of)-------+     
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |      |            |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 10 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +--------COMP:N-N(of)-------+     
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |      |            |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 11 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            +--------COMP:N-N(of)-------+     
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            |           +-MOD_ATT:N-ADJ-+     
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |      |            |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 12 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +--------COMP:N-N(of)-------+     
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |      |            |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 13 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            +--------COMP:N-N(of)-------+     
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            |           +-MOD_ATT:N-ADJ-+     
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |      |            |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 14 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                              
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            +--------COMP:N-N(of)-------+     
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 15 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                              
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            +--------COMP:N-N(of)-------+     
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 16 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +--------COMP:N-N(of)-------+     
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |      |            |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 17 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +--------COMP:N-N(of)-------+     
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |      |            |               |              |                |            |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 18 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +--------COMP:N-N(of)-------+     
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 19 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +--------COMP:N-N(of)-------+     
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 20 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                              
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            +--------COMP:N-N(of)-------+     
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 21 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                              
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            +--------COMP:N-N(of)-------+     
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 22 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +--------COMP:N-N(of)-------+     
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
Analyse 23 
       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                              
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                              
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +--------COMP:N-N(of)-------+     
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +-MOD_ATT:N-ADJ-+     
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |       +MOD_ATT+     
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |       |       |     
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ __NODE__ mRNA(s) .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)